Alpha Crest Capital Management LLC Regenxbio Inc. Transaction History

Alpha Crest Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $172,340 - $240,170	-7,000 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$30.19 - $40.28 $211,330 - $281,960	7,000 New	7,000 $229,000
Q1 2021 May 13, 2021	SELL	$33.61 - $49.95 $252,075 - $374,625	-7,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $198,900 - $370,125	7,500 New	7,500 $340,000
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $208,550 - $525,740	-9,700 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$34.54 - $44.87 $55,264 - $71,792	1,600 Added 19.75%	9,700 $397,000
Q3 2019 Nov 12, 2019	BUY	$31.84 - $50.88 $257,904 - $412,128	8,100 New	8,100 $288,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $413M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.